3 results match your criteria: "The Institute of Seizon and Life Sciences[Affiliation]"
Research Quality of Clinical Trials Reported for Foods with Function Claims in Japan, 2023-2024: Evaluation Based on a Revised Tool to Assess Risk of Bias in Randomized Trials.
Nutrients
August 2024
The Institute of Seizon and Life Sciences, 4-5-1 Ginza, Chuo-ku 104-0061, Tokyo, Japan.
Article Synopsis
- The Foods with Function Claim was initiated in Japan in April 2015 to increase the availability of health-labeled products, requiring strong scientific backing from clinical trials (CTs).
- A study evaluated 38 recent clinical trials using the RoB 2 tool, which measures the risk of bias in randomized trials, revealing that 76% of the trials had a high risk of bias.
- The most significant bias was found in the selection of reported results, undermining the overall quality of the trials, which was low across all evaluated domains.
A Cross-Sectional Study Based on Forty Systematic Reviews of Foods with Function Claims (FFC) in Japan: Quality Assessment Using AMSTAR 2.
Nutrients
April 2023
Research Institute of Pharmaceutical Sciences, Musashino University, 1-1-20 Aramachi, Nishitokyo, Tokyo 202-8585, Japan.
Background: The Foods with Function Claims (FFC) was introduced in Japan in April 2015 to make more products available that are labeled with health functions. The products' functionality of function claims must be explained by scientific evidence presented in systematic reviews (SRs), but the quality of recent SRs is unclear. This study assessed the quality of SRs in the FFC registered on the Consumer Affairs Agency (CAA) website in Japan.
View Article and Find Full Text PDFWe discuss the term "compassionate use" (CU) as an example of terminology having a huge impact on drug regulation. CU is used in many confusing situations, and its meaning varies significantly. We ethically affirm the necessity of CU.
View Article and Find Full Text PDF